Skip to content

Evaluation of Performances and Safety of the Medical Device Blueback® Physio for Patients With Chronic Low Back Pain

CompletedNot applicableNCT04592094
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The main objective of this clinical investigation is to show the superiority of a rehabilitation based on the use of Blueback® Physio compared to a rehabilitation without the use of Blueback® Physio in terms of reducing the time needed for a patient to control the voluntary contraction of the transversus abdominal muscle and to return to autonomy.

Study details

Official title
Evaluation of Performances and Safety of the Medical Device Blueback® Physio for Patients With Chronic Low Back Pain
Interventions
  • Device: Blueback® Physio
Sponsor
Blueback
Collaborators
Slb Pharma
Start date
2020-11-16
Primary completion
2022-12-07
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
France
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Included in the PRESDO program, * Suffering from chronic low back pain (= low back pain installed for more than 2 months), * Beneficiary of a social security, * For which his consent has been obtained in writing with regard to his participation in the protocol. Exclusion Criteria: * Bedridden or using a wheelchair, * Having a contraindication to performing the muscular exercises provided for in the protocol, * Having any other condition which, in the opinion of healthcare professionals, could affect its ability to complete the study or could present a significant risk, * Simultaneously participating in another clinical research protocol or having recently participated in another research for which the exclusion period has not been completed.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04592094